LSB Corp history

Unable to obtain suitable supplies for his students to perform their experiments, he founded Carolina Biological Supply in 1927 to provide dissection specimens.

Hoffmann-La Roche officially entered the lab business when it acquired the Kings County Research Laboratory in 1969.

In 1970, the lab moved from its location at Elon College to an old empty hospital in Burlington.

The company was founded in 1971 and is headquartered in Burlington, NC.“

After a few laboratory acquisitions, Revlon’s laboratory business adopted the name National Health Laboratories Incorporated (NHL) in 1974, and NHL was operated as a wholly owned subsidiary of Revlon Holdings, Inc.

In 1979 Biomedical sold stock to the public for the first time.

1982: Biomedical is acquired by Hoffman-LaRoche.

In 1983, Hoffmann-La Roche merged all of its laboratory companies into one company, which it called Roche Biomedical Laboratories (RBL).

In 1984, the United States Congress approved more stringent Medicare regulations, which forced testing laboratories to provide greater billing information.

In February 1987, Roche Biomedical joined with Pragma Bio-Tech, Inc., a New Jersey-based company, to provide workplace drug and alcohol testing.

In 1989, the company established a new division, the Roche Insurance Laboratory.

At the start of the 1990s, Roche Biomedical consolidated geographically, selling its western regional operations in August 1990.

In 1992, it agreed to refund $100 million to the federal government and $10 million to state-funded insurance programs, and pay a $1 million fine for billing for unnecessary blood tests.

NHL grew to $761 million in revenue by 1993.

The merger between National Health and Roche Biomedical was announced in December 1994.

In 1995, the company had gotten onto the list of 600 biggest companies and grown close to a $1.8 billion business with 20,000 employees.

Quest Diagnostic Incorporated, LabCorp's largest rival, had acquired SmithKline Beecham Clinical Laboratories in 1999, removing an aggressive price competitor.

In July 2000, LabCorp acquired Los Angeles-based National Genetics Institute, allowing LabCorp to gain NGI’s ultra-sensitive hepatitis C testing capability.

In 2001, ViroMed, one of the leading laboratories in molecular microbial testing using real-time PCR platforms, became a part of LabCorp.

LabCorp acquired Dynacare with locations in Washington, Tennessee, Wisconsin, and Canada in June 2002.

In 2005, LabCorp acquired Esoterix, Inc. and its leading specialty labs – Colorado Coagulation, Endocrine Sciences, and Cytometry Associates.

In 2006, LabCorp acquired Litholink, a premier provider for assisting physicians and their patients with outcomes management.

Since King became CEO in 2007, the company has gone to No.

Effective December 1, 2010, LabCorp successfully completed its acquisition of Genzyme Genetics, a business unit of Genzyme Corporation.

On December 15, 2011, LabCorp acquired Orchid Cellmark, Inc. (“Orchid”), harmonizing two experienced and highly-qualified forensics and family relationship laboratories.